Five Things to Know about HIV
Ending the epidemic starts and ends with each of us. Here are five critical things about HIV that you may not have learned in health class. Take a look below, learn something new about where we are in the fight to end the epidemic, and share this info with people you know.
1. We Are Not a “Risk”
People living with HIV who are taking HIV medications consistently and have an undetectable viral load do not transmit HIV to other people.
Early and consistent HIV treatment—the standard of care for everyone living with HIV—is one of the most effective ways to curb the spread of the virus. Most people living with HIV who are able to consistently take HIV medications achieve an undetectable viral load in just a month or two—and then will not transmit HIV to others. Ensuring that all of us living with HIV have access to affordable HIV care is critical to our health—and also HIV prevention efforts.Learn more about U Equals U
2. There is Power in Prevention with PrEP
HIV-negative people can take a pill to stop HIV in its tracks. It’s called PrEP, and when taken as intended, it’s more than 99% effective in preventing HIV infection with few side effects.
PrEP is an HIV-prevention innovation that could prevent the 38,500 HIV infections that happen every year in the U.S.—but not everybody knows about it. Help spread the word that PrEP is an option for every HIV-negative person—and that many people are able to access this prevention for free.Learn More about PrEP
3. Needless Fear of HIV Affects Our Lives
In the era of effective and available treatment we can’t let misinformation, fear and stigma continue to plague our community.
Stigma pushes us all to the margins—making it more difficult for people to know their status, talk about HIV with sex partners, and get support if they’re living with HIV. From the language we use to unjust laws criminalizing HIV, so many things give rise to harmful environments that devalue and stigmatize people living with HIV.
See what our community had to say about how stigma harms health, impedes sex and dating and what we can do to end HIV stigma.Learn more about HIV Stigma
4. HIV Meds Enable Us to Live Long Lives
Modern HIV medications are potent, effective and come with fewer side effects than ever before—enabling people who take them regularly to live long and healthy lives.
By the year 2020, an estimated 6.9 million people living with HIV will be over the age of 50. Attention is now turning to this so-called “greying of the HIV epidemic,” and ways that the community and health care providers can support people with co-occurring health conditions such as cancer, heart problems and inflammatory conditions.
See the incredible impact that modern-day HIV medication have had on improving the lifespans of people living with HIV, and find out what healthy aging with HIV looks like.Learn more about HIV Meds
5. Know Your Status
Needless fears about HIV can make getting tested scary, but knowing your status is the first step in taking charge of your health.
It’s estimated that 15% of people living with HIV in the U.S.—165,000 people—haven’t been diagnosed. Starting treatment not only helps people with HIV improve their own health, but also prevents transmission to others. This World AIDS Day, consider the last time you’ve been tested, and share info on where and how to get tested with family and friends.Learn More about HIV & STI Testing
Glory holes, anonymous sex & safer cruising during COVID-19
Queer people have always have and always will find creative ways to get our needs met. So it’s no surprise that people are developing innovative harm reduction strategies to have safer sex as we live with COVID-19.
Given the recent developments regarding the coronavirus, we’re providing information about how to prevent the spread of COVID-19 and changes to our programs and services.
Does PrEP work for trans people taking gender-affirming hormones? Yes, says new research
People taking gender-affirming hormones may use PrEP with confidence, said Robert M. Grant, MD, MPH.
“Tremendously exciting” news of cabotegravir long-acting injectable for PrEP shared at AIDS 2020
Final results of the HPTN 083 study show that for men who have sex with men and transgender women, a cabotegravir injection provided highly effective HIV prevention when given once every two months.
High effectiveness and adherence to PrEP 2-1-1 in large San Francisco AIDS Foundation study
At AIDS 2020, San Francisco AIDS Foundation presented positive findings from one of the largest pre-exposure prophylaxis (PrEP) 2-1-1 adherence and effectiveness studies to date.
How to afford PrEP and HIV meds if you lose health insurance
There are a variety of free programs that can help people afford medications and care even if they don’t have insurance. Read on for advice from Reina Hernandez, a PrEP benefits and HIV linkage manager from San Francisco
Undetectable to viral rebound: When and why?
New research finds that 1 in 13 people experienced viral rebound after becoming undetectable, with disparities related to race, housing status, age, and more.
I disagree with a “return to normal” after COVID-19
The current systems of this country are killing Black people. Instead of blaming Black people or relying on racist tropes, it’s time to fix systems to ensure health equity for all people, writes Preston Vargas.